<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">344048</id>
  <title nil="true"/>
  <common-name>2-[[4-(3-methylphenyl)-5-[(4-methylphenyl)sulfanylmethyl]-1,2,4-triazol-3-yl]sulfanyl]-n-[2-(trifluoromethyl)phenyl]acetamide</common-name>
  <description>2-[[4-(3-methylphenyl)-5-[(4-methylphenyl)sulfanylmethyl]-1,2,4-triazol-3-yl]sulfanyl]-n-[2-(trifluoromethyl)phenyl]acetamide is a chemical compound with the formula C26H23F3N4OS2. With an average molecular weight of 528.60 g/mol, 2-[[4-(3-methylphenyl)-5-[(4-methylphenyl)sulfanylmethyl]-1,2,4-triazol-3-yl]sulfanyl]-n-[2-(trifluoromethyl)phenyl]acetamide is a heavy molecule.</description>
  <cas>539811-32-0</cas>
  <pubchem-id>3695553</pubchem-id>
  <chemical-formula>C26H23F3N4OS2</chemical-formula>
  <weight>528.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T05:47:32Z</created-at>
  <updated-at type="dateTime">2026-08-31T05:47:32Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=C(C=C1)SCC2=NN=C(N2C3=CC=CC(=C3)C)SCC(=O)NC4=CC=CC=C4C(F)(F)F</moldb-smiles>
  <moldb-formula>C26H23F3N4OS2</moldb-formula>
  <moldb-inchi>InChI=1S/C26H23F3N4OS2/c1-17-10-12-20(13-11-17)35-15-23-31-32-25(33(23)19-7-5-6-18(2)14-19)36-16-24(34)30-22-9-4-3-8-21(22)26(27,28)29/h3-14H,15-16H2,1-2H3,(H,30,34)</moldb-inchi>
  <moldb-inchikey>IEOCLOPMJRHAOB-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">528.1265382</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM339941</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[4-(3-methylphenyl)-5-[(4-methylphenyl)sulfanylmethyl]-1,2,4-triazol-3-yl]sulfanyl]-n-[2-(trifluoromethyl)phenyl]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0294421</sync-id>
  <structure-inchikey>IEOCLOPMJRHAOB-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4000000000800000002800000000000000000004000000001000000200000000000002000004000000002080000000100000000000000000000000000000000000000000000000000000000020000000000000000000000010002000000000015010000000000000100000000010000100000000000800100004000001004140000000800000004000000080080000000100000090000001000000000000000000000010000000080000000000010004450000000000002400000000000000000000040000000000000000000000008000002000000200000000000000008140000000000040000000000480800008010000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:43:21Z</structure-indexed-at>
</compound>
